AI assistant
DAVITA INC. — Director's Dealing 2014
Feb 24, 2014
30643_dirs_2014-02-24_1c7e4db7-d7d5-4154-ae1e-c32dbad7e616.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-02-20
Reporting Person: DIAZ PAUL J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-20 | Common Stock | M | 24000 | $41.465 | Acquired | 27101 | Direct |
| 2014-02-20 | Common Stock | F | 15063 | $66.07 | Disposed | 12038 | Direct |
| 2014-02-20 | Common Stock | S | 8937 | $65.5516 | Disposed | 3101 | Direct |
| 2014-02-20 | Common Stock | M | 24000 | $42.465 | Acquired | 27101 | Direct |
| 2014-02-20 | Common Stock | F | 15426 | $66.07 | Disposed | 11675 | Direct |
| 2014-02-20 | Common Stock | S | 8574 | $65.6273 | Disposed | 3101 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-20 | Stock Appreciation Right | $41.465 | M | 24000 | Disposed | 2016-06-06 | Common Stock (24000) | Direct |
| 2014-02-20 | Stock Appreciation Right | $42.465 | M | 24000 | Disposed | 2017-06-11 | Common Stock (24000) | Direct |
Footnotes
F1: Represents the weighted average sale price of $65.5516. The range of prices for the sale of these shares was $65.39 - $65.59. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F2: Represents the weighted average sale price of $65.6273. The range of prices for the sale of these shares was $65.59 - $65.67. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F3: Stock Appreciation Rights, granted on June 6, 2011 pursuant to the DaVita HealthCare Partners Inc. 2011 Incentive Award Plan, which vested 100% on the first anniversary of the grant date.
F4: Stock Appreciation Rights, granted on June 11, 2012 pursuant to the DaVita HealthCare Partners Inc. 2011 Incentive Award Plan, which vested 100% on the first anniversary of the grant date.